NKGen Biotech has secured $2M in a funding round from a Japanese strategic investor to regain compliance with reporting obligations and standards.
Amount Raised
$2 Million
Round Type
Seed
Santa AnaBiotechnologyHealth CareInvestors
Description
NKGen Biotech announced it raised $2 million from a Japanese strategic investor to help bring its NK cell therapy to the Japanese market. This funding will aid in satisfying public company reporting requirements and ongoing debt obligations. Share trading will move to the OTC Expert Market temporarily. The company aims to return to NASDAQ or list on NYSE American after regaining compliance.
Quick answer
NKGen Biotech raised $2 Million in a Seed round, dated July 17, 2025. Investors: Japanese Strategic Investor. NKGen Biotech is based in Santa Ana, California, United States.
- How much did NKGen Biotech raise?
- NKGen Biotech raised $2 Million in a Seed round on July 17, 2025.
- Who invested in NKGen Biotech?
- Japanese Strategic Investor is named as investors in this round.
- What does NKGen Biotech do?
- NKGen Biotech, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of innovative natural killer cell therapeutics.
- Where is NKGen Biotech based and how big is it?
- NKGen Biotech is based in Santa Ana, California, United States. Fundz records about 58 employees.
- Who are the decision-makers at NKGen Biotech?
- Fundz holds 2 contacts at NKGen Biotech. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as NKGen Biotech that raised within 45 days of this round, from Fundz verified event records.
- Enlaza Therapeutics raised $15M on August 29, 2025.
- Modus Therapeutics raised $3M (Funding Round) on August 28, 2025.
- Seluna raised $874K (Funding Round) on August 28, 2025.
- PainTEQ raised an undisclosed amount (Funding Round) on August 27, 2025.
- Leal Therapeutics raised $30M (Series A) on August 27, 2025.
- Moonrise Medical raised $396K on August 27, 2025.
Who to call at NKGen Biotech, and when
A new round usually means NKGen Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day NKGen Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at NKGen Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at NKGen Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment NKGen Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
NKGen Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.